Ethnic variability associating gut and oral microbiome with obesity in children

Baskar Balakrishnan1, Vaithinathan Selvaraju2, Jun Chen3

  • 1Department of Immunology, Mayo Clinic , Rochester, MN, USA.

Gut Microbes
|February 18, 2021
PubMed

Insights

Obesity disparities in children are linked to gut and oral microbes. Microbial profiles differ by ethnicity, with specific bacteria associated with obesity in African American and European American children.

Area of Science:

  • Microbiome research
  • Pediatric health
  • Health disparities

Background:

  • Obesity is a global health concern, disproportionately affecting minority populations.
  • Early-life obesity requires identification of predictive indicators.
  • Understanding ethnic-specific microbial contributions to obesity is crucial.

Purpose of the Study:

  • To profile gut and oral microbiota associated with obesity in African American (AA) and European American (EA) children.
  • To identify microbial clades predictive of obesity status across different ethnicities.
  • To explore the influence of socioeconomic factors on ethnicity-specific microbial profiles.

Main Methods:

  • 16S rDNA sequencing of gut and saliva microbial communities.
  • Correlation analysis with salivary amylase and socioeconomic factors.
  • Comparison of microbial diversity (alpha, beta, taxa-level) between ethnic groups and obesity status.

Main Results:

  • Significant differences in gut and oral microbial diversity were observed between AA and EA children.
  • Gut microbes *Klebsiella* and *Magasphaera* abundance linked to obesity in AA children.
  • Oral microbes *Aggregatibacter* and *Eikenella* abundance linked to obesity in EA children.
  • Gut microbial diversity differences between obese and non-obese children were not evident in EA children.

Conclusions:

  • Gut and oral microbial profiles show ethnicity-specific associations with childhood obesity.
  • Socioeconomic factors modulate obesity-related microbiota in an ethnicity-dependent manner.
  • Tailored, population-specific strategies are needed to address childhood obesity.

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
85.4K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
919
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
101
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
279
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
75